BrainStorm Cell appoints Fiorino CEO BrainStorm Cell Therapeutics announced that it has appointed Tony Fiorino as its new CEO. Previously, Fiorino was founder, president and CEO of EnzymeRx, where he led the acquisition of a late-stage pre-clinical biologic and the development of the compound through Phase 1/2 clinical trials and its subsequent sale to 3SBio.
BrainStorm CEO underappreciated by investors, Feuerstein says BrainStorm CEO Tony Fiorino is "one of the most honest and diligent investors in the health care sector," TheStreet's Adam Feuerstein writes after interviewing the executive. Feuerstein believes Fiorino is being underappreciated by investors. Shares of the microcap company seeking to development a treatment for amyotrophic lateral sclerosis are up 20% to $4.15 in pre-open trading. Reference Link